Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1913 results about "Recombinant expression" patented technology

Recombinant expression is a process that allows an artificial gene, also known as a recombinant gene, to express the trait that is coded within it. This is done through DNA transcription, which converts the DNA into RNA that tells a cell to start making proteins, with the proteins themselves expressing the desired trait.

Humanized recombinant X VII collagen for promoting hair follicle stem cell repair and resisting aging as well as preparation method and application of humanized recombinant X VII collagen

The invention provides humanized recombinant XVII collagen for promoting hair follicle stem cell repair and resisting aging as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The humanized recombinant XVII type collagen comprises polypeptide derived from the XVII type collagen or repeated protein formed by N times of repeated series connection of the polypeptide serving as a unit, n is an integer from 2 to 4; the polypeptide derived from the XVII type collagen comprises a polypeptide A and / or a polypeptide B; the amino acid sequence of the A polypeptide is as shown in SEQ ID NO: 1; and the amino acid sequence of the B polypeptide is as shown in SEQ ID NO: 2. The humanized recombinant XVII type collagen not only can be massively and stably recombined and expressed, but also has cell adhesion activity, cell proliferation promotion activity, cell migration promotion activity and excellent hair follicle repair and regeneration promotion activity, and has no sensitization side effect. The invention provides a new way for preparing collagen products with rich functions.
Owner:SHANGHAI MEICUI MEILI HEALTH TECHNOLOGY DEVELOPMENT CO LTD

Streptomyces recombinant engineering strain for producing mycosporine-like metabolite as well as construction method and application of streptomyces recombinant engineering strain

The invention discloses a streptomycete recombinant engineering strain for producing mycosporine-like metabolites, a gene expression cassette is integrated in a genome of the streptomycete recombinant engineering strain, the gene expression cassette is recombined to an attB site of a chromosome in a streptomycete chassis strain, the gene expression cassette is an operon controlled by a single promoter, and the operon is an operon controlled by a single promoter. The operon comprises 2-4 biosynthetic gene elements in MysA, MysB, MysC and MysD or mysDp334 in a synthetic pathway of mycosporine-like metabolites. The invention also discloses a construction method of the streptomyces recombinant engineering strain and an application of the streptomyces recombinant engineering strain in preparation of the mycosporine-like metabolites. A mycosporine-like metabolite is efficiently produced by heterologous expression of a mycosporine-like metabolite synthesis gene element in streptomyces, and four mycosporine-like metabolite products with high yield and strong ultraviolet absorption activity can be obtained by reconstruction of the biosynthesis gene element and recombinant expression in streptomyces pluvialis.
Owner:HAINAN RES INST OF ZHEJIANG UNIV

Mutant of Burkholderia lipase as well as recombinant expression vector and application thereof

The invention relates to the technical field of bioengineering, and discloses a mutant of Burkholderia lipase as well as a recombinant expression vector and application of the mutant, the mutant comprises P131S, T132A, T251A, T251S, P131A, P131Q, T132G, Q88S and P113A single processes; and a Q88S double process and a P113A double process; and a multi-site mutation combination: a combination I: Q88S, P113A, T132G and L287S, and a combination II: Q88S, P113A, T132G and L287S; a combination II: Q88S, P113A, P131S and L287S; and a combination III: Q88S, P113A, P131S and T251A. Based on experiments, the invention finds that each mutant can not only improve the protein yield, but also improve the enzyme activity by 57% at most; ePA enrichment experiments find that the EPA content of the mutant can be increased by 33% at most, and the mutant has excellent EPA purification and enrichment effects.
Owner:成都圆大生物科技有限公司

Recombinant III-type humanized collagen as well as coding gene and application thereof

The invention belongs to the technical field of bioengineering, and particularly relates to recombinant III-type humanized collagen as well as a coding gene and application thereof. According to the invention, a novel III-type humanized collagen sequence is designed by adopting an advanced AI technology and molecular dynamics simulation, so that the recombinant III-type humanized collagen product is ensured to have high stability and degradation resistance. According to the invention, the screened new III-type humanized collagen sequence is transferred to the pichia pastoris strain for recombinant expression, and the prepared recombinant III-type humanized collagen has the advantages of strong stability, high expression quantity and good hydrophilicity, and meanwhile, the recombinant III-type humanized collagen also has obvious effects of promoting cell proliferation and cell adhesion.
Owner:ZHUHAI JINBAIKANG BIOLOGICAL TECH CO LTD

PgEGY3 gene for improving cold resistance of pennisetum alopecuroides and increasing fresh weight of leaves and application of PgEGY3 gene

The invention discloses a PgEGY3 gene for improving cold resistance of pennisetum alopecuroides and increasing fresh weight of leaves and application of the PgEGY3 gene, and relates to the technical field of genetic engineering, and the nucleotide sequence of the PgEGY3 gene of the pennisetum alopecuroides is shown as SEQ ID NO.1. The invention also discloses a protein coded by the Pennisetum alopecuroides PgEGY3 gene. The invention also discloses a recombinant expression vector and a recombinant host cell comprising the Pennisetum alopecuroides PgEGY3 gene. The invention also discloses application of the PgEGY3 gene, a recombinant expression vector and a recombinant host cell in improving cold resistance and biomass of pennisetum alopecuroides. It is verified that the Pennisetum alopecuroides PgEGY3 gene can improve the cold resistance of plants, and the growth state of the plants under cold stress is remarkably improved through overexpression of the PgEGY3 gene.
Owner:AGRI GENOMICS INST CHINESE ACADEMY OF AGRI SCI

Recombinant expression vector, recombinant strain and primer pair of pennisetum purpureum PpMYB2 gene, method for improving cold resistance of plant and application of related materials in improving cold resistance of plant

ActiveCN121022921ABacteriaClimate change adaptationBiotechnologyCold tolerant
The invention relates to the field of gene engineering for enhancing the cold resistance of plants, and relates to a recombinant expression vector, a recombinant strain and a primer pair of a pennisetum purpureum PpMYB2 gene, a method for improving the cold resistance of the plants and application of related materials in improving the cold resistance of the plants. One purpose of the invention is to provide application of the Pennisetum purpureum PpMYB2 gene and related materials thereof in improving the cold resistance of the plant, the amino acid sequence of the encoding protein of the Pennisetum purpureum PpMYB2 gene is as shown in SEQ ID NO.1, and the plant is arabidopsis thaliana or Pennisetum purpureum. Under the background that extreme low temperature events caused by global climate change are increasingly frequent, the cold resistance enhancing technology provided by the invention has important significance on guaranteeing the stability of agricultural production and reducing loss caused by low temperature. Through overexpression of the gene PpMYB2, the adaptability of perennial pennisetum purpureum to low-temperature stress can be remarkably improved, so that the planting range of perennial pennisetum purpureum is expanded to regions with lower temperature, and the survival and growth performance in different ecological environments is enhanced.
Owner:INST OF URBAN AGRI CHINESE ACADEMY OF AGRI SCI +1

Preparation method and application of chicken P4HB protein polyclonal antibody

The invention discloses a preparation method and application of a rabbit anti-chicken P4HB protein polyclonal antibody, and the preparation method comprises the following steps: amplifying a chicken P4HB gene by using a PCR (Polymerase Chain Reaction) method, and carrying out homologous recombination on the chicken P4HB gene into a pCOLDII carrier to construct a prokaryotic recombinant expression plasmid pCOLDII-P4HB; the recombinant plasmid is converted into E.coli BL21 (DE3), IPTG is used for induction expression, a Ni-NTA affinity chromatography method is used for protein purification, purified HIS-P4HB protein and an isometric Freund's complete adjuvant are mixed and emulsified, a New Zealand white rabbit is immunized with the purified protein, neck and back multi-point subcutaneous injection is adopted, and the antibody is cryopreserved in a-80 DEG C refrigerator after being subjected to Protein A + G affinity chromatography purification. The prokaryotically expressed HIS-P4HB protein is expressed in a competent cell supernatant, and the molecular mass is about 25KDa; after an experimental rabbit immunizes the P4HB recombinant protein for four times, blood sampling and serum separation are carried out, and after purification, the antibody can identify expression and cell localization of native conformation and linearized P4HB protein through Western blot and IF.
Owner:YANGZHOU UNIV

Recombinant vector for expressing LPL, recombinant bacterium and LPL production method

The invention provides a recombinant vector for expressing LPL, a recombinant bacterium and an LPL production method, and belongs to the technical field of gene engineering. The invention provides a recombinant expression vector of Pseudomonas aeruginosa lipoprotein lipase LPL, wherein an LPL coding gene is derived from Pseudomonas aeruginosa. The recombinant expression vector is introduced into a pseudomonas aeruginosa PAO1 cell, an expression strain is successfully constructed, the expression quantity of target protein is improved, efficient expression of LPL in PAO1 is achieved, and the produced LPL is high in enzyme activity and wider in application range.
Owner:JIAPU TIANCHENG (SHANGHAI) BIOTECHNOLOGY CO LTD

Camel source single-domain antibody GH12 for recognizing conformation B cell epitope in clostridium difficile glutamate dehydrogenase and application of camel source single-domain antibody GH12

The invention discloses a camel source single-domain antibody GH12 for recognizing a conformation B cell epitope in clostridium difficile glutamate dehydrogenase and application of the camel source single-domain antibody GH12. The nucleotide sequence of the camel source single-domain antibody GH12 is shown as SEQ ID NO: 1, and the amino acid sequence of the camel source single-domain antibody GH12 is shown as SEQ ID NO: 2. The camel source single-domain antibody GH12 disclosed by the invention has the advantages of strong specificity, high sensitivity, good accuracy and the like, and it is proved that the camel source single-domain antibody GH12 can be used for detecting recombinant expressed CD-GDH and endogenous CD-GDH by enzyme-linked immunosorbent assay (ELISA), protein dot blot hybridization (DB) and other methods.
Owner:ZHEJIANG MEDICAL COLLEGE

Multi-enzyme cascade catalytic reaction system for synthesizing trehalose-6-phosphoric acid and application of multi-enzyme cascade catalytic reaction system

The invention discloses a multienzyme cascade catalytic reaction system for synthesizing trehalose-6-phosphoric acid and application of the multienzyme cascade catalytic reaction system, and belongs to the technical field of biological catalysis. According to the invention, maltose phosphorylase, polyphosphate glucokinase, trehalose-6-phosphate phosphorylase and polyphosphate kinase are subjected to in-vitro recombinant expression to construct a multi-enzyme cascade catalytic reaction system containing the enzymes, and the synthesis of trehalose-6-phosphate by catalyzing the raw material maltose through the multi-enzyme cascade catalytic reaction system is realized; according to the method, the raw material utilization rate is high, the conversion efficiency from maltose to the target product trehalose-6-phosphoric acid reaches 90%, the highest level reported at home and abroad at present is achieved, and a foundation is laid for industrial synthesis of trehalose-6-phosphoric acid.
Owner:DALIAN UNIV OF TECH

Recombinant III-type humanized collagen and application thereof

The invention belongs to the technical field of bioengineering, and particularly relates to recombinant III-type humanized collagen and application thereof. Area fragments with good hydrophilicity in a human III-type collagen alpha chain are selected and sequentially connected to serve as expression protein, the amino acid sequence is 100% identical to that of a corresponding part of natural human III-type collagen, and immunological rejection cannot be generated when the human III-type collagen is applied to a human body. According to the invention, the screened new III-type humanized collagen sequence is transferred into pichia pastoris for recombinant expression, the prepared recombinant III-type humanized collagen has the advantages of strong stability, high expression quantity and good hydrophilicity, and meanwhile, the recombinant III-type humanized collagen also has obvious effects of promoting cell proliferation and cell adhesion.
Owner:ZHUHAI JINBAIKANG BIOLOGICAL TECH CO LTD

Humanized III-type collagen as well as preparation method and application thereof

The invention discloses humanized III-type collagen as well as a preparation method and application thereof, and belongs to the technical field of bioengineering. According to the method, firstly, on the basis of an original humanized III-type collagen gene, cell adhesion activity is taken as an evaluation index, a better cell adhesion sequence is screened out and spliced and integrated with the original collagen gene, and brand-new humanized III-type collagen is obtained. And constructing a recombinant expression vector of the humanized III type collagen containing the adhesion sequence by taking the probiotic EcN as a host cell, and introducing the recombinant expression vector into the EcN to obtain a strain of functional recombinant probiotic. Compared with a traditional escherichia coli engineering bacterium BL21 (DE3), the recombinant probiotics have good cell adhesion activity while efficiently expressing the humanized type III collagen, the bacterial endotoxin content of the recombinant humanized type III collagen obtained through purification meets the industrial standard, and the recombinant probiotics have good application prospects. The purification cost caused by industrial removal of endotoxin can be avoided, so that the production cost is reduced, and the method has a good application prospect.
Owner:EAST CHINA NORMAL UNIV

Anti-BCMA single-domain antibody, and preparation method therefor and use thereof

Provided are an anti-BCMA single-domain antibody, and a preparation method therefor and the use thereof. Specifically, provided is a single-domain antibody having an amino acid sequence of SEQ ID No. 1. The single-domain antibody has high affinity, can thoroughly specifically target BCMA-positive cells, and can be applied to the detection of BCMA expression in bone marrow cells of MM patients. The single-domain antibody can be prepared into a specific antibody drug clinically used for preventing and treating BCMA-target-related diseases (such as multiple myeloma, B-cell acute lymphoblastic leukemia, non-Hodgkin's lymphoma and Hodgkin's lymphoma); or a BCMA protein detection kit, etc. The single-domain antibody has a stable structure, a small molecular size, is easily recombinantly expressed and has a low production cost, can be used alone or as a drug delivery system to carry relevant drugs, and has very wide prospects and important significance in fields such as drug application and clinical diagnosis.
Owner:CARBIOGENE THERAPEUTICS CO LTD

Alginate lyase Alyw203 mutant with improved thermal stability

The invention belongs to the field of enzymes, and particularly relates to an alginate lyase Alyw203 mutant with improved thermal stability. According to the invention, mutation is carried out on the basis of alginate lyase Alyw203, and mutants with mutation sites of D40W, S136I, L172V, T206W and D248L are obtained. The thermal stability of the mutant is improved, the improvement of the mutant L172V is most obvious, and the residual activity of the mutant after being incubated at 40 DEG C for 1 hour is improved from 30.46% to 76.59%; the half-life period at 40 DEG C is prolonged to 388.78 min, which is 10.91 times that of the original enzyme, and 37.80% of residual enzyme activity still exists after incubation for 12 h. The invention also provides a coding gene of the mutant, a recombinant expression vector for producing the mutant and a genetically engineered bacterium.
Owner:QINGDAO JUDAYANG MARINE TECHNOLOGY CO LTD +1

Collagenase mutant, gene segment, recombinant plasmid, recombinant expression system, collagen peptide, and preparation method and application thereof

ActiveCN119570766AConnective tissue peptidesFungiCollagenanEndoenzyme
The invention discloses a collagenase mutant, a gene segment, a recombinant plasmid, a recombinant expression system, a collagen peptide, and a preparation method and application thereof, and belongs to the field of gene engineering and fermentation engineering. The collagenase mutant KT513 with high specific activity is obtained through recombinant expression in a trichoderma reesei host, and the enzyme activity of the collagenase mutant KT513 reaches 7423.18 U / mL. The optimum action pH of the enzyme is 3.0, the red snapper scale collagen can be subjected to enzymolysis in the pH range of 3.0-5.0, and the enzyme has excellent enzymolysis activity. After the collagenase mutant KT513 is subjected to enzymolysis at 40 DEG C for 4 hours, the extraction rate of fish scale collagen reaches 80.09%, and the prepared collagen peptide has good antioxidant activity. When the addition concentration is 10 mg / mL, the in-vitro scavenging activity of the prepared collagen peptide on hydroxyl radicals reaches 99.26% and is equivalent to that of ascorbic acid, and the collagen peptide has a wide application prospect in preparation of antioxidant preparations.
Owner:HUBEI KAITAI BIOTECHNOLOGY CO LTD

SGNH family esterase SH2 screened in Tibet hot spring environment and application of SGNH family esterase SH2

The invention discloses SGNH family esterase SH2 screened in a Tibetan hot spring environment and application of the SGNH family esterase SH2, and belongs to the technical field of gene engineering. According to the invention, a new SGNH family esterase gene is screened from a Tibetan hot spring environment, and recombinant expression is realized in escherichia coli. The recombinant esterase prepared by the invention has the characteristics of thermal stability, salt resistance, organic solvent resistance and the like, can be safely applied to tooth whitening or skin exfoliating products, avoids damage of traditional chemical bleaching agents to enamel, and has important application value in the fields of daily chemicals, medicines, food processing and the like.
Owner:SHENZHEN SIYOMICRO BIO TECH CO LTD +1

BaP4H mutant and application thereof

The invention provides a BaP4H mutant and application thereof, and belongs to the technical field of enzyme engineering, the BaP4H mutant is mutated on an amino acid sequence as shown in SEQ ID NO.1; the invention further provides a recombinant expression vector for expressing the BaP4H mutant, a recombinant cell, a preparation method and application. According to the BaP4H mutant provided by the invention, the recombinant collagen proline is efficiently hydroxylated, and the stability of the recombinant collagen is enhanced.
Owner:DONGGUAN EVERON HEALTHCARE CO LTD

Preparation and characterization method of cat serum albumin

The invention relates to the technical field of gene engineering, in particular to a cat serum albumin preparation and characterization method. The cat serum albumin gene sequence is optimized, a recombinant expression vector is successfully constructed, pichia pastoris genetically engineered bacteria are prepared, high-yield expression of the cat serum albumin gene in pichia pastoris is achieved, a purification system is established and perfected, and a pure product with the purity larger than 98% is obtained through affinity exchange column purification. Compared with the natural cat serum albumin, the cat serum albumin has a secondary structure, stability and antioxidant activity which are consistent with those of the natural cat serum albumin, has the characteristic of low hemolytic activity, can realize large-scale efficient production, can be applied to development of pet foods and medicines, and has wide application value and market prospect.
Owner:FEED RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Recombinant human type iv collagen and preparation method therefor

The present invention relates to a recombinant human type IV collagen and a preparation method therefor, which belong to the technical field of bioengineering. A recombinant human type IV collagen is designed on the basis of a partial sequence in an α2 chain of human type-IV collagen, and DNA encoding of the protein is ligated into an expression vector to construct a recombinant expression vector; then the recombinant expression vector is transformed into competent Escherichia coli cells, and a recombinant expression plasmid is extracted; after the plasmid is linearized, the linearized plasmid is transformed into an engineered strain HCPB-PPKEX2 to obtain a recombinant engineered strain; and the engineered strain is cultured, the expression of a target protein is induced, and the target protein is purified and identified. It is further demonstrated experimentally that the collagen can be completely cleaved by Kex2, Ste13 and CPB enzymes and efficiently secreted and expressed extracellularly, and the obtained sequence is completely consistent with a theoretical sequence. It is also verified experimentally that the recombinant collagen has a cell adhesion activity and a cell migration-promoting activity. The method avoids the risk of residual exogenous proteins, shortens the time and reduces the cost of the subsequent purification process, and thus has a relatively high safety and application value.
Owner:JIANGSU TRAUTEC MEDICAL TECH CO LTD

Alginate lyase AlgL3199 mutant, recombinant expression vector and genetically engineered bacterium

The invention belongs to the field of enzymes, and particularly relates to an alginate lyase AlgL3199 mutant, a recombinant expression vector and a genetically engineered bacterium. The invention provides an alginate lyase AlgL3199, and mutation is carried out on the basis of the alginate lyase AlgL3199 to obtain a mutant of which the mutation sites are K81A, D148P, V163T, I274G and a combination of the K81A, the D148P, the V163T and the I274G. The specific activity of the mutant enzyme and the thermal stability of a part of mutants are improved, the thermal stability of a mutation site K81A is improved most remarkably, the residual activity of the mutant enzyme after being incubated at 60 DEG C for 2 hours is retained by 52.97%, and the half-life period is 123.12 min and is 5.18 times that of an original enzyme. The invention further provides the alginate lyase AlgL3199, a coding gene of the mutant of the alginate lyase AlgL3199, a recombinant expression vector for producing the alginate lyase and a genetic engineering bacterium.
Owner:YELLOW SEA FISHERIES RES INST CHINESE ACAD OF FISHERIES SCI

Application of scylla antibacterial peptide Scin in preparation of anti-inflammatory composition and preparation method of scylla antibacterial peptide Scin

The invention discloses application of scylla serrata antibacterial peptide Scycin in preparation of an anti-inflammatory composition and a preparation method of the scylla serrata antibacterial peptide Scycin. The nucleotide sequence of the scylla serrata antibacterial peptide Scycin is shown as SEQ ID NO.01. The invention further discloses a preparation method of the scylla serrata antibacterial peptide Scycin. In an LPS (lipopolysaccharide)-induced RAW 264.7 macrophage inflammation model, the recombinant expression plasmid vector containing the scylla antibacterial peptide Scin remarkably inhibits an inflammation cascade reaction by down-regulating expression of proinflammatory factors such as TNF-alpha (tumor necrosis factor-alpha) and IL-6 (interleukin-6), the anti-inflammatory effect of the recombinant expression plasmid vector is equivalent to that of a mesalazine positive control group, and obvious cytotoxicity is not observed.
Owner:XIAMEN UNIV

Mutant photo-induced ion channel ChR-2 protein and application thereof

PendingCN121045353APeptide/protein ingredientsAlgae/lichens peptidesIon Channel ProteinMutant
The invention relates to the technical field of biomedicine, discloses mutant photo-induced ion channel ChR-2 protein, and further discloses a nucleic acid construct, an expression vector, a cell, related application and a computer model. The light-sensitive channel ChR2 protein mutant obtained by the invention has stronger light current, and the light-sensitive capability of the light-sensitive channel ChR2 protein mutant is at least improved by 100 times; besides, the invention also obtains a nucleotide sequence for coding the light-sensitive channel ChR2 protein mutant, constructs a recombinant expression vector, and obtains the light-sensitive channel ChR2 protein with higher expression quantity and stronger light sensitivity, and the light-sensitive channel ChR2 protein is very suitable for expression in cells of mammals (especially human); according to the invention, the rhodopsin in different channels is systematically studied by modifying the position G224 in the helix 6 of seven transmembrane helix motifs, which proves that the mutation of the position G224 in the helix 6 in WT ChR2 accelerates the photosensitivity of the channels, and the considered position is homologous in the helix 6 of the rhodopsin in different channels.
Owner:CHONGQING UNIV OF POSTS & TELECOMM

Site-specific antibody-drug conjugation through glycoengineering

The current disclosure provides binding polypeptides (e.g., antibodies), and effector moiety conjugates thereof (e.g., antibody-drug conjugates or ADCs), comprising a site-specifically engineered drug-glycan linkage within native or engineered glycans of the binding polypetpide. The current disclosure also provides nucleic acids encoding the antigen-binding polypeptides, recombinant expression vectors and host cells for making such antigen-binding polypeptides. Methods of using the antigen-binding polypeptides disclosed herein to treat disease are also provided.
Owner:GENZYME CORP

Recombinant expression vector, clostridium aerovorans engineering bacterium with micro-aerobic tolerance and construction method and application of clostridium aerovorans engineering bacterium

The invention relates to the technical field of biology, in particular to a recombinant expression vector, clostridium aerovorans engineering bacteria with micro-aerobic tolerance and a construction method and application of the clostridium aerovorans engineering bacteria. Functional elements of the recombinant vector are all from clostridium ethanolicum, the recombinant expression vector comprises a first recombinant expression vector and a second recombinant expression vector, and the first recombinant expression vector comprises a molecular chaperone CaDnaK as shown in SEQ ID NO.1 and a carbon monoxide dehydrogenase mutant as shown in SEQ ID NO.2 which are expressed in series; the second recombinant expression vector comprises formate dehydrogenase CaFdhF as shown in SEQ ID NO.3 and a hydrogenase mutant as shown in SEQ ID NO.4, wherein the formate dehydrogenase CaFdhF and the hydrogenase mutant are expressed in series; the recombinant expression vector is introduced into clostridium aerovorans, so that the viability of the strain and the conversion efficiency of a gas substrate in a micro-aerobic fermentation environment can be comprehensively improved, the industrial fermentation deoxygenization cost is reduced, and finally, the synthesis gas fermentation income is increased.
Owner:BEIJING SHOUGANG LANZATECH TECH CO LTD

Laccase mutant and application thereof in preparation of polyflavone by oxidative conversion of daidzein

ActiveCN119242602Ahigh optimum temperatureImprove temperature adaptabilityOrganic active ingredientsAntibacterial agentsCoprinopsis cinereaDaidzein
The invention discloses a laccase mutant and application of the laccase mutant in preparation of polyflavone by oxidative conversion of daidzein. According to the invention, laccase Lcc5 of coprinus cinerea is used as a starting enzyme, and through molecular docking, a position structure is analyzed, and mutation is designed. Synthesizing a mutant gene, and constructing a recombinant expression engineering bacterium of the mutant gene. After engineering bacteria containing mutant genes are subjected to induced expression, the Lcc5 mutant Lcc5-T485E is obtained through separation and purification, the specific enzyme activity and ethanol tolerance of the mutant are improved, and the conversion rate of daidzein is increased to about 1.26 times under the same enzyme activity; the antioxidant activity, the enzyme inhibition activity and the antibacterial activity of the obtained conversion product are also remarkably improved. The mutant enzyme has potential application value in oxidative conversion of daidzein and improvement of biological value of daidzein.
Owner:ANHUI UNIV

Method for identifying compound for inhibiting synthesis of vomitoxin from wheat stem rot pathogen

The invention belongs to the technical field of agricultural microorganisms, and particularly relates to a method for identifying a compound for inhibiting synthesis of vomitoxin from wheat stem rot pathogen. The method comprises the following steps: cloning an open expression cassette of a key catalytic enzyme gene FpgTri4 in a process of biologically synthesizing vomitoxin by pathogenic bacteria, constructing recombinant expression plasmids from the open expression cassette, and transduction the recombinant expression plasmids into a Fusarium pseudograminearum strain to induce expression to generate toxosome; and the inhibitor with inhibition on the generation of vomitoxin can inhibit the generation of toxosome in the recombinant strain, so that the related inhibitor can be screened by using the method. The method disclosed by the invention is rapid, simple and easy to implement, can be used for high-throughput screening, explores compounds capable of preventing diseases and controlling toxicity, and has important significance on scientific prevention and treatment of wheat stem rot.
Owner:ANHUI AGRICULTURAL UNIVERSITY

Lipase mutant and application thereof in preparation of epoxide

ActiveCN119432807AHigh substrate concentrationreduce dosageOrganic chemistryBacteriaPeroxy acidDouble bond
The invention relates to a lipase mutant and application thereof in preparation of epoxide, in particular to a lipase mutant which is derived from Tilletia indica and has remarkably improved peroxidation activity, a coding nucleic acid of the lipase mutant, a recombinant expression vector and a recombinant expression transformant containing a nucleic acid sequence, and an application of the lipase mutant in preparation of epoxide. The recombinant lipase or the recombinant expression transformant is used as a catalyst for preparing peroxy acid, and the peroxy acid reacts with olefin to generate epoxide. Compared with other methods (including a chemical method or a biological method and the like) for preparing alpha-epoxy pinane, the enzyme and the technical method thereof disclosed by the invention have the advantages of mild reaction conditions, environmental friendliness, lower cost, simplicity and convenience in operation, easiness in amplification and the like, and have a very good application prospect in the field of producing epoxy products by taking carbon-carbon double bonds as substrates.
Owner:EAST CHINA UNIV OF SCI & TECH

Novel biosynthesis path for producing 3 '-phosphoadenosine-5'-phosphosulfuric acid and application of 3 '-phosphoadenosine-5'-phosphosulfuric acid

The invention discloses a novel biosynthesis path for producing 3 '-phosphoadenosine-5'-phosphosulfuric acid and application, and belongs to the technical field of bioengineering. According to the invention, through recombinant expression and purification of ribose kinase, ribose phosphate pyrophosphate kinase, ribose phosphate transferase, adenine thiotransferase, adenosine phosphate sulfate kinase and polyphosphate kinase 2, a six-enzyme cascade reaction taking ribose and adenosine as substrates in vitro is constructed, the molar conversion rate reaches 22.85%, and the escherichia coli and bacillus subtilis PAPS cell factory can be used for preparing the recombinant ribose phosphate pyrophosphate kinase, the ribose phosphate transferase, the adenine thiotransferase, the adenosine phosphate sulfate kinase and the polyphosphate kinase 2. The yield of PAPS in a 5-L fermentation tank reaches 7.60 g / L and 5.03 g / L respectively. The PAPS synthesis route provided by the invention provides an extensible, economical and efficient solution for the production of sulfated compounds.
Owner:JIANGNAN UNIV